Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakkum

Showing results (321-330 of 347) with videos related to

Pageof 35
Sort By:
Gynecologic Oncology|December 4, 2012
Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173Robert L Coleman, Shamshad Ali, Charles F Levenback, et al.
Gynecologic Oncology|February 14, 2015
Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tamponsJamie N Bakkum-Gamez, Nicolas Wentzensen, Matthew J Maurer, et al.
JAMA Network Open|July 7, 2026
Patient-Centered Approach to Surgical Prevention of Ovarian Cancer: A Nonrandomized Clinical TrialKaren H Lu, Barbara M Norquist, Gary B Chisholm, et al.
Cancer & Metabolism|June 16, 2015
Erratum to: Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancerDebarshi Roy, Susmita Mondal, Chen Wang, et al.
Gynecologic Oncology|February 14, 2017
Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group studyPhuong L Mai, Marion Piedmonte, Paul K Han, et al.
Cancer & Metabolism|September 17, 2014
Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancerDebarshi Roy, Susmita Mondal, Chen Wang, et al.
Plos One|January 24, 2022
Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up careSven van Egmond, Ella D van Vliet, Marlies Wakkee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218Angeles Alvarez Secord, Kirsten Bell Burdett, Kouros Owzar, et al.
Gynecologic Oncology|June 5, 2026
Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 updateGregg Nelson, Alon D Altman, Amy Metcalfe, et al.
Oral Oncology|September 17, 2023
Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated diseaseKathleen R Bartemes, Benjamin R Gochanour, David M Routman, et al.
Pageof 35

Showing results (321-330 of 347) with videos related to

Sort By:
Pageof 35
Gynecologic Oncology|December 4, 2012
Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173Robert L Coleman, Shamshad Ali, Charles F Levenback, et al.
Gynecologic Oncology|February 14, 2015
Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tamponsJamie N Bakkum-Gamez, Nicolas Wentzensen, Matthew J Maurer, et al.
JAMA Network Open|July 7, 2026
Patient-Centered Approach to Surgical Prevention of Ovarian Cancer: A Nonrandomized Clinical TrialKaren H Lu, Barbara M Norquist, Gary B Chisholm, et al.
Cancer & Metabolism|June 16, 2015
Erratum to: Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancerDebarshi Roy, Susmita Mondal, Chen Wang, et al.
Gynecologic Oncology|February 14, 2017
Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group studyPhuong L Mai, Marion Piedmonte, Paul K Han, et al.
Cancer & Metabolism|September 17, 2014
Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancerDebarshi Roy, Susmita Mondal, Chen Wang, et al.
Plos One|January 24, 2022
Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up careSven van Egmond, Ella D van Vliet, Marlies Wakkee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218Angeles Alvarez Secord, Kirsten Bell Burdett, Kouros Owzar, et al.
Gynecologic Oncology|June 5, 2026
Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 updateGregg Nelson, Alon D Altman, Amy Metcalfe, et al.
Oral Oncology|September 17, 2023
Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated diseaseKathleen R Bartemes, Benjamin R Gochanour, David M Routman, et al.
Pageof 35